SCHEMBL31153787

SCHEMBL31153787

CC(C)(C)[Si](C)(C)OC[C@H]1CNCCN1C1CCN(C(=O)OCc2ccccc2)CC1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.46
NPC1 O15118 2/20 0.46
RAB9A P51151 2/20 0.46
CYP2C19 P33261 1/20 0.44
HTT P42858 1/20 0.43
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
GRIN2B Q13224 10/20 0.42
CYP2D6 P10635 4/20 0.41
CYP2C9 P11712 4/20 0.41
CYP3A4 P08684 3/20 0.41
FAAH O00519 1/20 0.41
HTR2C P28335 1/20 0.41
JAK2 O60674 1/20 0.39
JAK1 P23458 1/20 0.39
TYK2 P29597 1/20 0.39
JAK3 P52333 1/20 0.39
CHRM2 P08172 1/20 0.39
CHRM1 P11229 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31153942 0.82 PARP1 (0.47) SMN1; SMN2NPC1RAB9ACYP2C19HTT
Tert-Butyl Formate SCHEMBL27991334 0.80 SMN1; SMN2 (0.46) SMN1; SMN2NPC1RAB9ACYP2C19HTT
SCHEMBL30741167 0.78 SMN1; SMN2 (0.45) SMN1; SMN2NPC1RAB9ACYP2C19HTT
SCHEMBL29560191 0.77 SMN1; SMN2 (0.45) SMN1; SMN2NPC1RAB9ACYP2C19
SCHEMBL22836694 0.75 SMN1; SMN2 (0.61) SMN1; SMN2NPC1RAB9ACYP2C19HTT
SCHEMBL6475398 0.75 PREP (0.49) NPSR1
SCHEMBL6475389 0.75 PREP (0.49) NPSR1
SCHEMBL6484219 0.75 PREP (0.49) NPSR1
SCHEMBL20129642 0.74 MEN1 (0.45) SMN1; SMN2NPC1RAB9ACYP2C19HTT
SCHEMBL5105600 0.74 SMN1; SMN2 (0.55) SMN1; SMN2NPC1RAB9ACYP2C19HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024220399-A1 PYRAZOLOTRIAZINECARBONITRILES USEFUL AS KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2024-10-24 WO disclosed